Recursion Pharmaceuticals (NASDAQ: RXRX) is doing so specifically within the biotech niche, but the company's efforts haven't ...

UIUC and Stanford's RecursiveMAS lets AI agents collaborate in embedding space instead of text, cutting token usage by 75% ...

AI, accelerated by systems such as Mythos, is beginning to transform into a strategic weapon surpassing nuclear arms.

Round led by PXN Ventures, with additional funding from existing investors IQ Capital and Northern Gritstone * Company uses quantum physics, AI m ...

Collaboration with PacBio will generate long-read bulk RNA-seq data to advance patient-level prediction from tumor transcriptomesSAN FRANCISCO--(BUSINESS WIRE)--Blank Bio, an applied AI research lab ...

The company's closed-loop platform is designed to dramatically speed up enzyme development for pharmaceuticals, sustainable ...

A Manchester-based techbio company using AI and quantum physics to engineer better enzymes faster, has closed a £5 million ...

Round led by PXN Ventures, with additional funding from existing investors IQ Capital and Northern Gritstone Company uses quantum physics, AI modelling and deeply integrated laboratory automation ...

OpenAI is offering a $445,000 research role focused on self-improving AI systems, and the job listing has generated serious ...

Discover 25 terrifying things AI can already do that will shock you. From predicting crimes to deepfakes and emotion reading, ...

Manchester techbio spin-out Imperagen has secured £5m in seed funding to scale an AI-powered enzyme engineering platform born out of research at The University of Manchester. The round was led by PXN ...

In The Lancet in 1971, Julian Tudor Hart gave medicine one of its most important insights: the availability of medical care ...